SCHEMBL4929889

SCHEMBL4929889

Cc1nc(Nc2ccc3occc3c2)sc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 10/20 0.53
PKM P14618 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
RAB9A P51151 6/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
KDM4E B2RXH2 3/20 0.48
MAPT P10636 4/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
LMNA P02545 2/20 0.47
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
NPC1 O15118 5/20 0.47
HPGD P15428 2/20 0.47
ALDH1A1 P00352 2/20 0.47
POLB P06746 1/20 0.47
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5353754 0.85 DHODH (0.40) DHODHRAB9AKDM4EMAPTMEN1
SCHEMBL5355961 0.83 DHODH (0.53) DHODHSMN1; SMN2KDM4EMAPTMEN1
SCHEMBL27706868 0.77 SMN1; SMN2 (0.76) DHODHRAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL4765972 0.76 NPC1 (0.76) DHODHRAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL14184605 0.76 RAB9A (0.53) DHODHRAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL27706920 0.76 RAB9A (0.80) DHODHRAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL4928409 0.75 NPC1 (0.70) DHODHRAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL4914862 0.75 MAPT (0.70) DHODHRAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL4923649 0.75 SMN1; SMN2 (0.59) DHODHRAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL5360044 0.75 ALDH1A1 (0.41) PKMTDP1RAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US claimed
EP-1819330-A1 5-CARBOXAMIDO SUBSTITUED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE KV FAMILY Devgen N.V. (BE) 2007-08-22 EP claimed
WO-2006058905-A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY DEVGEN NV (BE) 2006-06-08 WO claimed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family KCNA5, KCNA1, KCNJ2 DHODH 2479/4885PKM 476/4885TDP1 2334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.